DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $659,000 | -9.8% | 4,765 | 0.0% | 0.03% | +14.8% |
| Q4 2019 | $731,000 | +6.1% | 4,765 | -0.1% | 0.03% | 0.0% |
| Q3 2019 | $689,000 | +2.5% | 4,770 | +1.4% | 0.03% | -3.6% |
| Q2 2019 | $672,000 | +8.2% | 4,705 | 0.0% | 0.03% | +3.7% |
| Q1 2019 | $621,000 | +27.0% | 4,705 | -0.8% | 0.03% | +12.5% |
| Q4 2018 | $489,000 | -8.1% | 4,745 | -3.1% | 0.02% | +9.1% |
| Q3 2018 | $532,000 | +10.1% | 4,895 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $483,000 | +0.6% | 4,895 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $480,000 | -2.4% | 4,895 | -7.6% | 0.02% | 0.0% |
| Q4 2017 | $492,000 | +4.2% | 5,295 | -3.6% | 0.02% | -4.3% |
| Q3 2017 | $472,000 | +5.6% | 5,495 | +3.8% | 0.02% | +4.5% |
| Q2 2017 | $447,000 | +76.0% | 5,295 | +78.0% | 0.02% | +15.8% |
| Q1 2017 | $254,000 | +9.5% | 2,975 | 0.0% | 0.02% | +5.6% |
| Q4 2016 | $232,000 | -0.4% | 2,975 | 0.0% | 0.02% | -5.3% |
| Q3 2016 | $233,000 | -28.7% | 2,975 | -8.2% | 0.02% | -29.6% |
| Q2 2016 | $327,000 | -10.9% | 3,241 | -16.1% | 0.03% | -12.9% |
| Q1 2016 | $367,000 | +58.9% | 3,865 | +55.2% | 0.03% | +55.0% |
| Q4 2015 | $231,000 | +13.8% | 2,490 | +4.4% | 0.02% | +5.3% |
| Q3 2015 | $203,000 | – | 2,385 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |